Pages that link to "Q40695890"

The following pages link to The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model (Q40695890):

Displaying 32 items.

• Yaba monkey tumor virus encodes a functional inhibitor of interleukin-18 (Q24657195) (← links)
• Modified Vaccinia Virus Ankara (Q28223836) (← links)
• The inflammasome as a target of modulation by DNA viruses (Q28388139) (← links)
• Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients (Q28943252) (← links)
• A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread (Q30528971) (← links)
• Diversity in the acute CD8 T cell response to vaccinia virus in humans (Q33227607) (← links)
• Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence (Q33910501) (← links)
• Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses (Q34059488) (← links)
• Introduction of the Six Major Genomic Deletions of Modified Vaccinia Virus Ankara (MVA) into the Parental Vaccinia Virus Is Not Sufficient To Reproduce an MVA-Like Phenotype in Cell Culture and in Mice (Q34120696) (← links)
• Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein (Q34182371) (← links)
• Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to inhibit NF-κB activation and promote immune evasion and virulence (Q34611139) (← links)
• Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia viruses (Q35023470) (← links)
• Poxvirus immunomodulatory strategies: current perspectives (Q35125981) (← links)
• Variola virus immune evasion proteins (Q35206879) (← links)
• Vaccinia virus pathogenicity in atopic dermatitis is caused by allergen-induced immune response that prevents the antiviral cellular and humoral immunity (Q35584019) (← links)
• Technical knockout: understanding poxvirus pathogenesis by selectively deleting viral immunomodulatory genes (Q35827465) (← links)
• The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense (Q36370571) (← links)
• Deletion of specific immune-modulatory genes from modified vaccinia virus Ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques (Q36397581) (← links)
• Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity (Q36464830) (← links)
• Vaccinia virus F1L protein promotes virulence by inhibiting inflammasome activation (Q36835632) (← links)
• Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens. (Q36911682) (← links)
• Serro 2 Virus Highlights the Fundamental Genomic and Biological Features of a Natural Vaccinia Virus Infecting Humans (Q37539293) (← links)
• IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenic (Q37617613) (← links)
• Viral interference with innate immunity by preventing NF-κB activity (Q37952350) (← links)
• Identification of residues in an orthopoxvirus interleukin-18 binding protein involved in ligand binding and species specificity (Q40546391) (← links)
• Variola virus IL-18 binding protein interacts with three human IL-18 residues that are part of a binding site for human IL-18 receptor alpha subunit (Q41836613) (← links)
• Predicting the subcellular localization of viral proteins within a mammalian host cell (Q42414674) (← links)
• The genomic sequence of ectromelia virus, the causative agent of mousepox (Q42615527) (← links)
• Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory (Q50533334) (← links)
• New insights into the immunomodulatory properties of poxvirus cytokine decoy receptors at the cell surface. (Q55314189) (← links)
• A virus-encoded type I interferon decoy receptor enables evasion of host immunity through cell-surface binding (Q60300348) (← links)
• Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics (Q60913456) (← links)